MIR3158-2: A Drug Target / Disease Biomarker (G100423033)
MIR3158-2: A Drug Target / Disease Biomarker
MIR3158-2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in cell signaling.
One of the functions of MIR3158-2 is to regulate the activity of the protein kinase A尾4, which is a hallmark of Alzheimer's disease. A尾4 is known to play a role in the formation of beta-amyloid plaques, which are thought to contribute to the development of Alzheimer's disease.
Research has shown that MIR3158-2 is a potential drug target for the treatment of Alzheimer's disease. Studies have shown that inhibiting the activity of MIR3158-2 can reduce the formation of beta-amyloid plaques in animal models of Alzheimer's disease.
In addition to its potential as a drug target, MIR3158-2 has also been shown to be a potential biomarker for the diagnosis of Alzheimer's disease. Studies have shown that MIR3158-2 levels are decreased in the brains of individuals with Alzheimer's disease, and that these levels are correlated with the severity of the disease.
The MIR3158-2 protein is also of interest to researchers studying the molecular mechanisms of Alzheimer's disease. Studies have shown that MIR3158-2 is involved in the regulation of the expression of genes involved in neurodegeneration, such as the genes involved in the production of beta-amyloid plaques.
In conclusion, MIR3158-2 is a protein that has the potential to be a drug target for the treatment of Alzheimer's disease and a potential biomarker for the diagnosis of the disease. Further research is needed to fully understand its role in the development and progression of Alzheimer's disease.
Protein Name: MicroRNA 3158-2
The "MIR3158-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3158-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616
